Here’s what you need to know about Mr. Boyle:
1. He has 26 years of commercial experience in the in vitro diagnostics and life sciences industry.
2. Prior to joining Clinical Genomics, he served as vice president of Qiagen. In this role, he led the company’s business portfolio in tuberculosis management.
3. His other positions include president of Cellestis and general manager of the United Kingdom subsidiary of Diagnostic Systems Laboratories.
More articles on gastroenterology and endoscopy:
Which lifestyle factors are associated with serrated colorectal polyps? 5 study insights
AGA critiques ABIM maintenance of certification announcement: 3 takeaways
Biggest hepatology breakthroughs in 2016: Nonalcoholic steatohepatitis, primary biliary cholangitis
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.